Today: 1 May 2026
Browse Category

NASDAQ:GLW 28 January 2026 - 30 March 2026

AI ETFs 2026: Why Vanguard VGT, Roundhill CHAT and Value-Chain Funds Are Pulling Investors Beyond Nvidia

AI ETFs 2026: Why Vanguard VGT, Roundhill CHAT and Value-Chain Funds Are Pulling Investors Beyond Nvidia

Vanguard Information Technology ETF fell 1.0%, Roundhill Generative AI & Technology ETF dropped 1.1%, and Global X Artificial Intelligence & Technology ETF lost 0.8% Monday morning as investors shifted focus from megacap tech to chip and hardware suppliers. U.S. equity funds saw $37.24 billion in inflows last week, but tech sector funds lost $1.45 billion.
30 March 2026
········
Corning stock drops after CFO update, a day after Gorilla Glass Ceramic 3 launch

Corning stock drops after CFO update, a day after Gorilla Glass Ceramic 3 launch

Corning shares dropped 4.3% to $151.04 Tuesday afternoon, reversing part of Monday’s gains after the CFO’s remarks at a Morgan Stanley conference and new product news with Motorola. The decline outpaced the broader market, with the S&P 500 ETF down 0.7%. Investors are reassessing Corning’s near-term prospects after a strong run driven by AI and data-center demand.
3 March 2026
··
Corning stock spikes to fresh highs after Citi lifts target to $170 ahead of OFC

Corning stock spikes to fresh highs after Citi lifts target to $170 ahead of OFC

Corning shares surged 5.3% to $159.57 Wednesday, hitting a record $160.76, as investors bet on its role in AI data-center infrastructure. Citi, Morgan Stanley, and Mizuho all raised price targets ahead of the Optical Fiber Communication conference in March. Corning’s $6 billion supply deal with Meta Platforms remains a key anchor. The next dividend of $0.28 per share goes ex-dividend Feb. 26.
25 February 2026
·
Corning stock (GLW) jumps again as AI data-center cable demand keeps the rally moving

Corning stock (GLW) jumps again as AI data-center cable demand keeps the rally moving

Corning shares climbed nearly 4% Tuesday, hitting a new 52-week high of $152.91 before trading at $150.99 in afternoon action. The stock has surged on heavy volume following a $6 billion supply deal with Meta and rising earnings forecasts. Monday’s close marked a second straight session of gains, with volume more than double the 50-day average. Investors await upcoming conference appearances and the next dividend record date.
24 February 2026
····
Corning stock hits fresh highs after UBS lifts target to $160 as AI-fiber trade rolls on

Corning stock hits fresh highs after UBS lifts target to $160 as AI-fiber trade rolls on

Corning shares jumped 7.3% to $139.51 Friday after UBS upgraded the stock on rising data-center fiber demand, briefly topping $140 for the first time. The move followed a multiyear Meta Platforms contract and comes as hyperscaler capex forecasts surge. Corning’s year-to-date gain neared 60%. Investors will watch for further contract news next week.
21 February 2026
···
Corning stock rises as market slides: what GLW traders are watching next

Corning stock rises as market slides: what GLW traders are watching next

Corning shares rose 1.4% to $111.86 Tuesday, outperforming major U.S. stock ETFs, after forecasting first-quarter sales above Wall Street estimates and announcing a multi-year Meta supply deal. SEC filings show insider sales on Feb. 2, including Eric Musser and Michael Paul O'Day. The stock traded between $109.64 and $117.50 amid volatility. Optical-fiber demand now accounts for nearly 40% of company revenue.
3 February 2026
·
Corning stock slides as traders digest Q1 outlook and Meta’s $6 billion fiber deal

Corning stock slides as traders digest Q1 outlook and Meta’s $6 billion fiber deal

Corning shares fell 3.2% to $106.18 by late morning Wednesday after volatile trading. The company reported fourth-quarter core sales up 14% to $4.41 billion and expects first-quarter core sales of $4.2–$4.3 billion, above estimates. Corning and Meta announced a U.S. data-center supply deal worth up to $6 billion, driving expansion in North Carolina.
28 January 2026
···

Stock Market Today

  • Seaport Therapeutics Upsizes IPO to $255M, CEO Highlights New Biotech Pathway
    May 1, 2026, 2:02 PM EDT. Seaport Therapeutics raised $254.9 million in an upsized Nasdaq IPO, exceeding initial $180 million estimates. CEO Daphne Zohar highlighted a shift from traditional M&A (mergers and acquisitions) to public offerings, reflecting confidence in developing and marketing their depression drug pipeline independently. The company may raise an additional $38.2 million through underwriters' option. Zohar pointed to industry changes where biotech firms are now focusing on advancing medicines directly to patients, citing success stories like Karuna Therapeutics and Intra-Cellular Therapies. Seaport's board recently welcomed Sharon Mates, who led Intra-Cellular to a $1.5 billion drug launch before its J&J acquisition. This IPO signals renewals in the biotech public market despite recent Big Pharma dealmaking.

Latest article

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

Dow Jones Today: Why the Blue-Chip Rally Stalled as Apple, S&P 500 and Nasdaq Pushed Higher

1 May 2026
The Dow Jones Industrial Average fell 78.72 points to 49,573.42 by midday Friday, reversing an early rally as tariff concerns weighed on gains from Apple and other strong earnings reports. President Donald Trump announced a 25% tariff on EU-made cars and trucks starting next week. Apple reported quarterly revenue of $111.2 billion, up 17% year over year. Oil prices dropped after Iran sent a new negotiation proposal.
US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

US Stock Market Today: Why the S&P 500 and Nasdaq Are Hitting Fresh Highs

1 May 2026
The S&P 500 rose 0.48% and the Nasdaq 0.96% to record highs Friday, while the Dow slipped 0.11%. Apple shares climbed after reporting its strongest quarterly sales growth in over four years. Atlassian and other software stocks rallied on strong cloud demand. Exxon and Chevron beat profit estimates but cited pressure from Middle East conflict and volatile oil prices.
Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

Recursion Pharmaceuticals Stock: Founder Chris Gibson to Leave Board as RXRX Nears Q1 Earnings

1 May 2026
Recursion Pharmaceuticals said founder and board chair Chris Gibson will not seek re-election at the June 17 annual meeting, months after stepping down as CEO. The company reports first-quarter results May 6, with investors watching for updates on cash, clinical progress, and its AI drug platform. Recursion last reported $753.9 million in cash and narrowed its quarterly net loss. Gibson will remain chair until his term ends.
Go toTop